AIM ImmunoTech Announces Further Efforts to Establish Clinical Trials Assessing Ampligen as a Potential Protective and Early-Onset Treatment for the Current COVID-19 Pandemic
Stock Information for AIM ImmunoTech Inc.
Loading
Please wait while we load your information from QuoteMedia.